316 related articles for article (PubMed ID: 34389031)
1. Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages.
Sun JL; Zhang NP; Xu RC; Zhang GC; Liu ZY; Abuduwaili W; Wang F; Yu XN; Shi X; Song GQ; Wu H; Liu TT; Shen XZ; Deng B; Weng SQ; Dong L; Zhu JM
J Transl Med; 2021 Aug; 19(1):347. PubMed ID: 34389031
[TBL] [Abstract][Full Text] [Related]
2. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X
Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012
[TBL] [Abstract][Full Text] [Related]
3. Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway.
Wang F; Xu WQ; Zhang WQ; Xu RC; Sun JL; Zhang GC; Liu ZY; Qi ZR; Dong L; Weng SQ; Shen XZ; Liu TT; Fang Y; Zhu JM
Hepatol Int; 2024 Apr; 18(2):636-650. PubMed ID: 37982952
[TBL] [Abstract][Full Text] [Related]
4. MiR-155 regulates M2 polarization of hepatitis B virus-infected tumour-associated macrophages which in turn regulates the malignant progression of hepatocellular carcinoma.
Fei Y; Wang Z; Huang M; Wu X; Hu F; Zhu J; Yu Y; Shen H; Wu Y; Xie G; Zhou Z
J Viral Hepat; 2023 May; 30(5):417-426. PubMed ID: 36704832
[TBL] [Abstract][Full Text] [Related]
5. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.
Qu X; Zhao X; Lin K; Wang N; Li X; Li S; Zhang L; Shi Y
Front Immunol; 2022; 13():994019. PubMed ID: 36177006
[TBL] [Abstract][Full Text] [Related]
6. PCSK9 Suppresses M2-Like Tumor-Associated Macrophage Polarization by Regulating the Secretion of OX40L from Hepatocellular Carcinoma Cells.
Hu J; Zhang M; Gui L; Wan Q; Zhong J; Bai L; He M
Immunol Invest; 2022 Aug; 51(6):1678-1693. PubMed ID: 35078374
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma.
Zhang Q; Tsui YM; Zhang VX; Lu AJ; Lee JM; Lee E; Cheung GC; Li PM; Cheung ET; Chia NH; Lo IL; Chan AC; Cheung TT; Ng IO; Ho DW
Theranostics; 2024; 14(2):892-910. PubMed ID: 38169544
[No Abstract] [Full Text] [Related]
8. The Transcription of
Gou Y; Yang D; Tian T; Zhu X; Zhang R; Ren J; Tu D; Luo Y; Miao Y; Zhao H; Wang Y; Wei B
Front Immunol; 2022; 13():725595. PubMed ID: 35371096
[TBL] [Abstract][Full Text] [Related]
9. SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages.
Li Z; Li H; Zhao ZB; Zhu W; Feng PP; Zhu XW; Gong JP
J Exp Clin Cancer Res; 2019 Nov; 38(1):469. PubMed ID: 31744516
[TBL] [Abstract][Full Text] [Related]
10. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
11. Targeting NAD
Sun Q; Shen M; Zhu S; Liao Y; Zhang D; Sun J; Guo Z; Wu L; Xiao L; Liu L
Hepatol Int; 2023 Dec; 17(6):1444-1460. PubMed ID: 37204655
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma-derived high mobility group box 1 triggers M2 macrophage polarization via a TLR2/NOX2/autophagy axis.
Shiau DJ; Kuo WT; Davuluri GVN; Shieh CC; Tsai PJ; Chen CC; Lin YS; Wu YZ; Hsiao YP; Chang CP
Sci Rep; 2020 Aug; 10(1):13582. PubMed ID: 32788720
[TBL] [Abstract][Full Text] [Related]
13. Codonopsis pilosula-derived glycopeptide dCP1 promotes the polarization of tumor-associated macrophage from M2-like to M1 phenotype.
Liu H; Yao M; Ren J
Cancer Immunol Immunother; 2024 May; 73(7):128. PubMed ID: 38743074
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment.
Petty AJ; Li A; Wang X; Dai R; Heyman B; Hsu D; Huang X; Yang Y
J Clin Invest; 2019 Dec; 129(12):5151-5162. PubMed ID: 31638600
[TBL] [Abstract][Full Text] [Related]
15. Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma.
Yu Z; Li Y; Li Y; Zhang J; Li M; Ji L; Tang Y; Zheng Y; Sheng J; Han Q; Li F; Guo J; Wang L; Sun X; Gao Y; Feng H
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618286
[TBL] [Abstract][Full Text] [Related]
16. M2 polarization of tumor-associated macrophages is dependent on integrin β3 via peroxisome proliferator-activated receptor-γ up-regulation in breast cancer.
Shu Y; Qin M; Song Y; Tang Q; Huang Y; Shen P; Lu Y
Immunology; 2020 Aug; 160(4):345-356. PubMed ID: 32311768
[TBL] [Abstract][Full Text] [Related]
17. Exosomes synergized with PIONs@E6 enhance their immunity against hepatocellular carcinoma via promoting M1 macrophages polarization.
Chen H; Jiang S; Zhang P; Ren Z; Wen J
Int Immunopharmacol; 2021 Oct; 99():107960. PubMed ID: 34284286
[TBL] [Abstract][Full Text] [Related]
18. Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling.
Zhang X; Lu X; Shi J; Li Y; Li Y; Tao R; Huang L; Tang Y; Zhu X; Li M; Gao Y; Feng H; Yu Z
Phytomedicine; 2024 Apr; 126():155395. PubMed ID: 38340578
[TBL] [Abstract][Full Text] [Related]
19. Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization.
Zhao X; Wang X; You Y; Wen D; Feng Z; Zhou Y; Que K; Gong J; Liu Z
Exp Cell Res; 2020 Jun; 391(1):111979. PubMed ID: 32246992
[TBL] [Abstract][Full Text] [Related]
20. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
